About the RBL
A unique facility designed to support the research community and national biodefense network by providing state-of-the-art Biosafety Level 3 (BSL-3) and Animal Biosafety Level 3
(ABSL-3) laboratories, including dedicated facilities for aerobiology, imaging, and immunopathology. The laboratory boasts a diverse group of scientists whose collective expertise in their
specialized fields provides unsurpassed service on all contracted and collaborative work.
The University of Pittsburgh has consistently been ranked among the top 10 in National Institutes of Health (NIH) funding during the past decade, and the Center for Vaccine Research
(CVR) at the University of Pittsburgh provides a wide array of opportunities for researchers. The CVR brings together scientists from varied disciplines with a common goal of investigating the
pathogenesis and immunology of emerging infectious diseases and biodefense pathogens. The Regional Biocontainment Laboratory (RBL) at the University of Pittsburgh is one of 13 facilities in the
nation funded by the NIH. As a component of the CVR, the mission of the RBL is to facilitate investigators in the development of new vaccines and therapeutics to combat these emerging and globally significant pathogenic agents. In pursuit of this mission, the RBL:
The RBL will conduct research on BSL-3 Category A, B and C priority pathogens that have an impact on the health of people around the world. With advanced research capacity and facilities, the RBL
will bring academia together with government and industry scientists to develop new vaccines, therapies, and diagnostics for these globally significant pathogens.
- Serves as a resource for biomedical researchers by providing access to BSL-3 enhanced containment laboratories and qualified scientists,
- Establishes partnerships with industry and academic institutions to facilitate collaborative research,
- Develops national and international collaborations for emerging infectious diseases, and
- Serves as a regional and national resource in the event of a natural or man-made outbreak of highly pathogenic infectious diseases.